| 000 | 01132 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250511175743.0 | ||
| 264 | 0 | _c19931018 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1992.tb51640.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTorchilin, V P | |
| 245 | 0 | 0 |
_aTargeting of thrombolytic agents: current state of knowledge and perspectives. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _cDec 1992 |
||
| 300 |
_a404-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aFibrinogen _xadministration & dosage |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aMagnetics |
| 650 | 0 | 4 |
_aThrombin _xadministration & dosage |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 667 _gp. 404-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1992.tb51640.x _zAvailable from publisher's website |
| 999 |
_c1315583 _d1315583 |
||